Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities
Net loss	$ (2,087,133)	$ (1,940,858)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization expense	33,174	275
Stock based compensation	236,470	25,567
Warrant issued for product development agreement	0	1,399,833
Changes in operating assets and liabilities:
Accounts receivable	(242,816)	24,730
Prepaid inventory	(308,003)	0
Prepaid expenses	(1,231)	(149)
Accounts payable and accrued expenses	619,652	(26)
Deferred revenue	732,620	0
Other liabilities	(6,465)	18,343
Cash Provided by (Used In) Operating Activities	(1,023,731)	(472,286)
Cash Flows from Investing Activities
Purchase of marketable securities	(6,999,927)	0
Purchase of equipment	(6,608)	(1,190)
Proceeds from reverse acquisition	0	29,536
Increase in other asset	(494)	(19,826)
Cash Provided by (Used In) Investing Activities	(7,007,029)	8,520
Cash Flow from Financing Activities
Repayments to (advances) from stockholders	0	(15,108)
Proceeds from sale of series D preferred shares	0	6,551,745
Proceeds from exercise of options and warrants	0	150,345
Cash Provided by Financing Activities	0	6,686,982
Net Increase in Cash	(8,030,760)	6,223,216
Cash, Beginning of the Period	11,131,175	71,799
Cash, End of the Period	3,100,415	6,295,015
NON-CASH FINANCING ACTIVITIES
Conversion of preferred stock to common stock	133	0
License	0	1,073,529
Accounts payable settled with Series D Preferred Stock	0	50,000
NET LIABILITIES ASSUMED IN REVERSE ACQUISITION
Cash	0	29,536
Prepaid expenses	0	14,483
Accounts receivable	0	1,000
Account payable	0	(46,150)
Accrued expenses	0	(83,094)
Net liability assumed	$ 0	$ (84,225)